Search alternatives:
codon optimization » wolf optimization (Expand Search)
based optimization » whale optimization (Expand Search)
immune based » mxene based (Expand Search)
binary pair » binary pairs (Expand Search)
Showing 1 - 20 results of 29 for search '(( binary pair codon optimization algorithm ) OR ( primary immune based optimization algorithm ))*', query time: 0.74s Refine Results
  1. 1
    AIPSO algorithm flowchart.

    AIPSO algorithm flowchart. by Xiaohui Liu (6412)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Data_Sheet_3_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning.csv

    Data_Sheet_3_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    Save to List
    Saved in:
  3. 3
    Data_Sheet_4_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning.csv

    Data_Sheet_4_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    Save to List
    Saved in:
  4. 4
    Data_Sheet_2_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning.csv

    Data_Sheet_2_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    Save to List
    Saved in:
  5. 5
    Data_Sheet_1_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning.csv

    Data_Sheet_1_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    Save to List
    Saved in:
  6. 6
    Data_Sheet_1_Robust optimization for casualty scheduling considering injury deterioration and point-edge mixed failures in early stage of post-earthquake relief.docx

    Data_Sheet_1_Robust optimization for casualty scheduling considering injury deterioration and point-edge mixed failures in early stage of post-earthquake relief.docx by Yufeng Zhou (3702208)

    Published 2023
    Save to List
    Saved in:
  7. 7
    Table_7_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_7_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  8. 8
    Image_3_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tif

    Image_3_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tif by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  9. 9
    Table_6_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_6_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  10. 10
    Table_2_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_2_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  11. 11
    Image_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tiff

    Image_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tiff by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  12. 12
    Table_5_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_5_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  13. 13
    Table_4_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_4_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  14. 14
    Table_3_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_3_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  15. 15
    Image_2_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tif

    Image_2_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.tif by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  16. 16
    Table_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv

    Table_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.csv by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  17. 17
    Data_Sheet_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.docx

    Data_Sheet_1_An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.docx by Cong Liu (66219)

    Published 2022
    Save to List
    Saved in:
  18. 18
    DataSheet1_Primary sarcopenia is associated with elevated spontaneous NET formation.pdf

    DataSheet1_Primary sarcopenia is associated with elevated spontaneous NET formation.pdf by Irina Balazs (18102253)

    Published 2024
    Save to List
    Saved in:
  19. 19
    Table_1_Development and validation of a multivariable nomogram predictive of hepatitis B e antigen seroconversion after pregnancy in hepatitis B virus-infected mothers.DOCX

    Table_1_Development and validation of a multivariable nomogram predictive of hepatitis B e antigen seroconversion after pregnancy in hepatitis B virus-infected mothers.DOCX by Wenting Zhong (11460046)

    Published 2024
    Save to List
    Saved in:
  20. 20
    Image 4_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf

    Image 4_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf by Liping Tang (77094)

    Published 2025
    “…We then applied ten machine learning algorithm to exosomal transcriptomic data to evaluate diagnostic performance and identify the optimal classifier. …”
    Save to List
    Saved in:

Search Tools: